BackPark Ha Biological Technology , Ltd. Overview

Park Ha Biological Technology , Ltd. Receivables

Track Park Ha Biological Technology , Ltd.'s receivables ($4.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$4.16M
↑ 496.19% YoYΔ $3.46M vs prior year quarter

Peer trimmed avg / median

Loading

Park Ha Biological Technology , Ltd. Receivables History

Loading

Park Ha Biological Technology , Ltd. vs. peers: Receivables Comparison

Loading

Park Ha Biological Technology , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Park Ha Biological Technology , Ltd. (PHH) FAQ

As of the most recent data (April 2025), PHH shows a receivables of $4.2M. That compares with $700K in the prior-year period — up 496.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PHH's receivables is now $4.2M (was $700K) — a 496.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Park Ha Biological Technology , Ltd. is outperforming or lagging.

Tracking PHH's receivables over time shows whether Park Ha Biological Technology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $4.2M That compares with $700K in the prior-year period — up 496.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Park Ha Biological Technology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $4.2M) with ownership activity and broader fundamentals.